<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04379882</url>
  </required_header>
  <id_info>
    <org_study_id>OC32 Silva</org_study_id>
    <nct_id>NCT04379882</nct_id>
  </id_info>
  <brief_title>Feasibility Study Evaluating the Silva Module During the Anaesthesiology Consultation Before an Elective Surgery</brief_title>
  <acronym>Silva</acronym>
  <official_title>Feasibility Study Evaluating the Silva Module During the Anaesthesiology Consultation Before an Elective Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oncomfort</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Erasme University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oncomfort</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this feasibility study, feasibility, acceptability and an initial clinical efficacy of the
      new module of Hypnosis and Virtual Reality (or Digital Sedation), Silva, will be evaluated.
      This feasibility study meets objectives of Oncomfort's design validation and design
      verification steps. Silva will be tested on a sample of 10 patients in the environment where
      the product is intended to be used, a hospital environment. If results do not fit with user
      needs, design will be adapted according to results and a new phase of design validation will
      be implemented. The Silva module is a Digital Sedation module designed for management of pain
      and anxiety in perioperative patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects will be recruited during the anaesthesiology consultation preparing to an elective
      surgery.

      First, subject will be asked to self-assess anxiety and comfort. In order to evaluate
      anxiety, subject will use a 0-10 rating Visual Analogue Scale (VAS) where 0 = no anxiety at
      all, and 10= the worst imaginable anxiety. The same scale will be used to measure the level
      of comfort where 0 means no comfort at all and 10 very comfortable.

      Subject should be positioned laying on a reclining chair during the session. This session
      will last for 30 minutes. After the experiment, participants will be asked to rate anxiety,
      level of comfort, level of immersion and dissociation.

      Several questions will be asked to the patient to evaluate his/ her experience, the Silva
      module, and the sensations experienced.

      The study will be ended by an evaluation of adverse event (AE) and the evaluation of the
      caregivers.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 10, 2020</start_date>
  <completion_date type="Anticipated">July 20, 2020</completion_date>
  <primary_completion_date type="Anticipated">July 10, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluate the acceptability and the patient's qualitative reported experience of Silva</measure>
    <time_frame>Day 1 of the intervention</time_frame>
    <description>questionnaire</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluate Anxiety</measure>
    <time_frame>Day 1 of the intervention</time_frame>
    <description>questionnaire VAS 0 (no anxiety)- 10 (max anxiety)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate Comfort</measure>
    <time_frame>Day 1 of the intervention</time_frame>
    <description>questionnaire VAS 0 (extreme discomfort)- 10 (extreme comfort)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of agreeability of the Digital Sedation session</measure>
    <time_frame>Day 1 of the intervention</time_frame>
    <description>questionnaire VAS (0-10) 0: not agreeable, 10: extremely agreeable</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Preoperative Anxiety</condition>
  <arm_group>
    <arm_group_label>Digital sedation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>30 minutes Silva module</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Digital Sedation (Silva)</intervention_name>
    <description>Use of Digital Sedation (virtual reality associated with psychological interventions) for preoperative anxiety management</description>
    <arm_group_label>Digital sedation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        â€¢ Subject more than 18 years old

        Exclusion Criteria:

          -  Deaf subject

          -  Blind

          -  Non-proficiency in French (Module language)

          -  Psychiatric disorder

          -  Head or face wounds

          -  Neurological disease

          -  Chronic pain and/or chronic analgesics consumption

          -  Medication affecting the autonomic nervous system

          -  Dizziness
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Turgay Tuna</last_name>
    <phone>02 555 3324</phone>
    <email>Turgay.Tuna@erasme.ulb.ac.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Diane Jooris</last_name>
    <phone>0475793354</phone>
    <email>diane@oncomfort.com</email>
  </overall_contact_backup>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>April 17, 2020</study_first_submitted>
  <study_first_submitted_qc>May 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 8, 2020</study_first_posted>
  <last_update_submitted>May 16, 2020</last_update_submitted>
  <last_update_submitted_qc>May 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

